Jame Abraham, Chairman and Professor of Department of Hematology and Medical Oncology at Cleveland Clinic, shared on LinkedIn about a recent paper by Marko Velimirovic published in JCO:
“Human Epidermal Growth Factor Receptor 2 Positivity a Moving Target in the Era of Antibody-Drug Conjugates.”
Authors: Marko Velimirovic and Jame Abraham
More posts featuring Jame Abraham.